Tina Susan Nova

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
San Diego, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Tina Nova
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Tina Susan Nova

Form 4 holding President, CLIA U.S.

VERACYTE, INC.

Security class
Stock Option (right to buy)
Shares / value
103,043
Estimated value
$2,735,792
Report date
03 Mar 2022
Price
$26.55
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding President, CLIA U.S.

VERACYTE, INC.

Security class
Common Stock
Shares / value
76,988
Estimated value
$2,043,262
Report date
03 Mar 2022
Price
$26.54
Ownership
Direct
Form 4 holding Director

Azenta, Inc.

Security class
Common
Shares / value
15,772
Estimated value
$439,250
Report date
06 Feb 2026
Price
$27.85
Ownership
Direct
Form 4 holding Director

EXAGEN INC.

Security class
Stock Option(right to buy)
Shares / value
13,500
Estimated value
$48,330
Report date
10 Jun 2025
Price
$3.58
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

ARENA PHARMACEUTICALS INC

Security class
Stock Option (right to buy)
Shares / value
0
Estimated value
Report date
11 Mar 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Tina Susan Nova

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .